首页> 美国政府科技报告 >120-Hour Continuous Intravenous Infusion Study of NSC-D629243 Rats.
【24h】

120-Hour Continuous Intravenous Infusion Study of NSC-D629243 Rats.

机译:NsC-D629243大鼠120小时连续静脉输注研究。

获取原文

摘要

The study was conducted to determine the potential target organ toxicity and its reversibility in rats of NSC-D629243 in 70 percent DMSO after 120-hours of continuous intravenous infusion. The study consisted of four groups of rats, 3/sex/group. Drug was infused at two different rates. Groups 1 and 2 (0 and 0.9 mg/kg/hr, respectively) were infused at a rate of 0.1 mL/kg/hr, while Groups 3 and 4 (0 and 2.6 mg/kg/hr, respectively) were infused at 0.3 mL/kg/hr. On Study Day 8, all males were sacrificed and on Study Day 34 all females were sacrificed. All animals survived until scheduled termination. There were no discernible signs of toxicity related to the continuous intravenous infusion of NSC-D629243. All signs of abnormality were related to the vehicle (70 percent DMSO). Infusion of DMSO produced destruction of erythrocytes by intravascular hemolysis, with the high solute load of hemoglobin and cellular contents producing hematuria and a slight transient rise in urine specific gravity. The anemia arising from hemolysis was judged to be regenerative, normochromic, and macrocytic in nature. There were no obvious differences in the response to flow rates of 0.1 or 0.3 mL/kg/hr DMSO. There was no evidence of histopathologic abnormality related to DMSO or NSC-D629243. All such signs of toxicity related to DMSO were reversed in the post-treatment phase.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号